Search
for
Sort by
Research 301–330 of 440
- Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Clinical and hepatic evaluation in adult dengue patients: a prospective two-month cohort study
- SARS-CoV-2 Non-Structural Proteins and Their Roles in Host Immune Evasion
- Treatment of pediatric alopecia areata: A systematic review
- Skin signs in anorexia nervosa
- Efficacy and safety of methotrexate in alopecia areata
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Prognosis, treatment, and disease outcomes in frontal fibrosing alopecia: A retrospective review of 92 cases
- Direct Vasodilators and Sympatholytic Agents
- Sarcoidosis: Are there differences in your skin of color patients?
- Outcomes in Clinically Relevant Patient Subgroups From the EMBRACA Study: Talazoparib vs Physician’s Choice Standard-of-Care Chemotherapy
- Bendamustine in Indolent Non-Hodgkin's Lymphoma: A Practice Guide for Patient Management
- Consensus on the treatment of alopecia areata – Brazilian Society of Dermatology
- The anti-inflammatory and analgesic activities of 2Br-Crebanine and Stephanine from Stephania yunnanenses H. S.Lo
- Structures of the SARS-CoV-2 spike glycoprotein and applications for novel drug development
- Specificity of anti-SSB as a diagnostic marker for the classification of systemic lupus erythematosus
- A randomized controlled clinical trial of recombinant interferon α‐2b in the treatment of acute post‐transfusion hepatitis C: A preliminary report
- The common regulatory pathway of COVID-19 and multiple inflammatory diseases and the molecular mechanism of cepharanthine in the treatment of COVID-19
- Systemic Minoxidil Accidental Exposure in a Paediatric Population: A Case Series Study of Cutaneous and Systemic Side Effects
- Chinese SLE Treatment and Research group (CSTAR) registry 2009–2019: Major clinical characteristics of Chinese patients with systemic lupus erythematosus
- Cutaneous manifestations associated with immune checkpoint inhibitors
- Efficacy and safety of trastuzumab deruxtecan in the treatment of HER2-low/positive advanced breast cancer: a single-arm meta-analysis
- Therapeutic efficacy and safety of Kang-ai injection combined with platinum-based doublet chemotherapy in advanced NSCLC: A meta-analysis
- Satisfaction with control of systemic lupus erythematosus and lupus nephritis: physician and patient perspectives
- Molecular Targeted Agents and Biologic Therapies for Non-small Cell Lung Cancer
- Presentation and Management of Cutaneous Manifestations of COVID-19
- Patient Recovery from COVID-19 Infections: Follow-Up of Hair, Nail, and Cutaneous Manifestations
- Comprehensive treatment of Cronkhite-Canada syndrome: A case report and literature review
- Bendamustine: an Old Drug in the New Era for Patients with Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia